Device Trial Radar · NCT00866814
Study Of Hernia Repair Utilizing The Bard Ventrio Hernia Patch
Last checked: Nov 19, 2026Latest source record: Oct 12, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
119
Actual
Start
Mar 2009
Primary completion
May 2011
Study completion May 2011
Sponsor
- Lead sponsor
- C. R. BardPublic (BDX)
- Sponsor type
- Industry
- Collaborators
- FGK Clinical Research GmbH
- First posted
- Mar 23, 2009
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will collect data on patients undergoing hernia repair using the Bard Ventrio Hernia Patch. The study will evaluate hernia recurrence rates, operating time, quality of life and complications associated with the device and surgical procedure.
Conditions
- Ventral Hernia
Interventions
Bard Ventrio Hernia PatchDevice
The Ventrio Hernia Patch is a self-expanding, non-absorbable, sterile prosthesis for use in the reconstruction of soft tissue deficiencies, such as for the repair of hernias.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Primary Endpoint is the Rate of Hernia Recurrence in Study Patients.Time frame: 1 year post surgery
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Sutter Medical Group GNS
Sacramento, California
Sacred Heart Health System, Inc.
Pensacola, Florida
RUSH Univeristy Medical Center
Chicago, Illinois
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.